SL Science Holding Ltd (NASDAQ:SLBT)
| Market Cap | $405.09M-90.8% |
| Revenue (ttm) | $1.13K |
| Net Income | -$1.60K |
| EPS | $0.00 |
| Shares Out | 560.76M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 318,905 |
| Open | $0.92 |
| Previous Close | $0.90 |
| Day's Range | $0.62 - $0.92 |
| 52-Week Range | $0.62 - $14.50 |
| Beta | 0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About SLBT
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
When insiders bought and sold
1 year · open-market trades only$SLBT stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in SLBT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SLBT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SLBT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New SLBT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SLBT from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from SLBT’s recent data — informational, not investment advice